Reuters logo
8 months ago
BRIEF-Sucampo Pharmaceuticals say issued $300 mln of convertible senior notes due 2021 - SEC filing
December 27, 2016 / 9:36 PM / 8 months ago

BRIEF-Sucampo Pharmaceuticals say issued $300 mln of convertible senior notes due 2021 - SEC filing

Dec 27 (Reuters) - Sucampo Pharmaceuticals Inc

* Sucampo Pharmaceuticals Inc - notes were issued to Leerink Partners LLC

* Sucampo Pharmaceuticals - on Dec 27, 2016, co issued $300.0 million aggregate principal amount of its 3.25 pct convertible senior notes due 2021 - SEC filing

* Sucampo Pharmaceuticals - to use net proceeds from note offering to repay in full approximately $238.4 million due under co's senior secured credit facility Source text: (bit.ly/2hLgZDP) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below